Cargando…
Combatting mucosal melanoma: recent advances and future perspectives
Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240847/ https://www.ncbi.nlm.nih.gov/pubmed/30459941 http://dx.doi.org/10.2217/mmt-2018-0003 |
_version_ | 1783371703414423552 |
---|---|
author | Tyrrell, Helen Payne, Miranda |
author_facet | Tyrrell, Helen Payne, Miranda |
author_sort | Tyrrell, Helen |
collection | PubMed |
description | Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based clinical guidelines are still in development in the UK. In this review we provide an overview of the management of mucosal melanoma, highlighting the critical differences between cutaneous and mucosal melanomas, before examining recent advances in the systemic treatment of this disease and likely future directions. |
format | Online Article Text |
id | pubmed-6240847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-62408472018-11-20 Combatting mucosal melanoma: recent advances and future perspectives Tyrrell, Helen Payne, Miranda Melanoma Manag Review Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based clinical guidelines are still in development in the UK. In this review we provide an overview of the management of mucosal melanoma, highlighting the critical differences between cutaneous and mucosal melanomas, before examining recent advances in the systemic treatment of this disease and likely future directions. Future Medicine Ltd 2018-10-08 /pmc/articles/PMC6240847/ /pubmed/30459941 http://dx.doi.org/10.2217/mmt-2018-0003 Text en © 2018 Miranda J Payne This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Review Tyrrell, Helen Payne, Miranda Combatting mucosal melanoma: recent advances and future perspectives |
title | Combatting mucosal melanoma: recent advances and future perspectives |
title_full | Combatting mucosal melanoma: recent advances and future perspectives |
title_fullStr | Combatting mucosal melanoma: recent advances and future perspectives |
title_full_unstemmed | Combatting mucosal melanoma: recent advances and future perspectives |
title_short | Combatting mucosal melanoma: recent advances and future perspectives |
title_sort | combatting mucosal melanoma: recent advances and future perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240847/ https://www.ncbi.nlm.nih.gov/pubmed/30459941 http://dx.doi.org/10.2217/mmt-2018-0003 |
work_keys_str_mv | AT tyrrellhelen combattingmucosalmelanomarecentadvancesandfutureperspectives AT paynemiranda combattingmucosalmelanomarecentadvancesandfutureperspectives |